Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

OBJECTIVE To determine the clinical consequences of acquiring Pseudomonas aeruginosa infection during early childhood in children with cystic fibrosis (CF). DESIGN Prospective, observational cohort study of 56 children with CF identified by newborn screening during 1990-92. Each child underwent an annual bronchial lavage during the first 2 to 3 years of life. Clinical outcome was determined at 7 years of age. RESULTS P aeruginosa infection was diagnosed in 24 (43%) cohort subjects. Four children died before 7 years of age, all of whom had been infected with a multi-resistant, mucoid strain of P aeruginosa (P =.04). In survivors, P aeruginosa infection was associated with significantly increased morbidity as measured by lower National Institutes of Health scores, greater variability in lung function, increased time in the hospital, and higher rates of recombinant human deoxyribonuclease therapy (P <.01). In this young CF cohort, best forced expiratory volume in 1 second was an insensitive measure of increased morbidity. CONCLUSIONS Acquisition of P aeruginosa was common by 7 years of age in this CF birth cohort and was associated with increased morbidity and mortality. An improved disease severity score would improve the evaluation and study of early CF lung disease.

[1]  C. Robertson,et al.  Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989‐1998) , 2000, The Medical journal of Australia.

[2]  J. Emerson,et al.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis , 1999, Pediatric pulmonology.

[3]  N. Høiby,et al.  Changing Epidemiology of Pseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974–1995) , 1999, Pediatric pulmonology.

[4]  J. Carlin,et al.  Severe viral respiratory infections in infants with cystic fibrosis , 1998, Pediatric pulmonology.

[5]  J. Hull,et al.  Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis , 1998, Thorax.

[6]  J. Carlin,et al.  Lower airway inflammation in infants and young children with cystic fibrosis. , 1997, American journal of respiratory and critical care medicine.

[7]  D. Gozal,et al.  Proceedings from the First International Symposium on the Congenital Central Hypoventilation Syndrome held in New Orleans, LA, on May 11, 1996 , 1997 .

[8]  J. Carlin,et al.  Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis , 1996, Pediatric pulmonology.

[9]  P. J. Byard,et al.  Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. , 1995, Journal of clinical epidemiology.

[10]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[11]  C. Wielinski,et al.  Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. , 1993, The Journal of pediatrics.

[12]  D. Woods,et al.  Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. , 1993, Pediatric pulmonology.

[13]  S. Fitzsimmons,et al.  The changing epidemiology of cystic fibrosis. , 1993, The Journal of pediatrics.

[14]  C. Mellis,et al.  Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis , 1992, Pediatric pulmonology.

[15]  B. Tümmler,et al.  New approaches in genome analysis by pulsed‐field gel electrophoresis: application to the analysis of Pseudomonas species , 1991, Molecular microbiology.

[16]  N. Høiby,et al.  Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment , 1991, The Lancet.

[17]  F. Accurso,et al.  Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. , 1991, The Journal of pediatrics.

[18]  R. Cowan,et al.  Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: Correlations between anti‐Pseudomonas aeruginosa antibody levels and pulmonary function , 1991, Pediatric pulmonology.

[19]  M. Corey,et al.  Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. , 1990, The Journal of pediatrics.

[20]  Buist As.  Standardization of spirometry. , 1987 .

[21]  R. Ramphal,et al.  Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation , 1980, Infection and immunity.

[22]  J. Kattwinkel,et al.  A new prognostic score and clinical evaluation system for cystic fibrosis. , 1973, The Journal of pediatrics.